[How to evaluate the long-term course of osteoarthritis. Tests for trials of fundamental treatments (spine excluded)]
- PMID: 2080413
[How to evaluate the long-term course of osteoarthritis. Tests for trials of fundamental treatments (spine excluded)]
Abstract
The best assessment tests for long term trials on osteoarthritis (OA) of the hip and knee are the following, in order of relevance value (consensus of french experts): 1) the loss of joint space thickness on successive radiographies; 2, 3) the indices of the severity for OA of the hip and knee; the investigator's overall opinion; 4) the patient's overall opinion (visual analogue scale of handicap); 5, 6, 7) the pain level (visual analogue scale); the time for going up and down a standard flight of stairs and the time of pain in this distance; the limitation of two articular movements; 8) the increase of either analgesics or NSAIDs consumption; 9) concerning OA of fingers, the number of joints newly involved on successive radiographies. At present, only the radiological tests 1 and 9 are validated. The clinical tests 2 to 8, valuable for short term trials, have yet to be validated for long term follow-up. Recommended duration of trials is three years. A rigorous organisation is necessary to avoid erroneous inclusions: all data recorded in the pre-inclusion visit have to be checked by the principal investigator. Since we have not yet a validated chondroprotective agent as a reference drug, the trial must be randomised, double blind, placebo controlled, parallel group study.
Similar articles
-
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.J Rheumatol. 2001 Nov;28(11):2494-503. J Rheumatol. 2001. PMID: 11708424
-
A 10-day course of SPA therapy is beneficial for people with severe knee osteoarthritis. A 24-week randomised, controlled pilot study.Clin Rheumatol. 2007 Dec;26(12):2063-2071. doi: 10.1007/s10067-007-0618-x. Epub 2007 Apr 13. Clin Rheumatol. 2007. PMID: 17431728 Clinical Trial.
-
Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.Am J Ther. 2011 Mar-Apr;18(2):170-7. doi: 10.1097/MJT.0b013e318209df49. Am J Ther. 2011. PMID: 21317618 Clinical Trial.
-
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.Osteoarthritis Cartilage. 2000 Nov;8(6):395-403. doi: 10.1053/joca.2000.0361. Osteoarthritis Cartilage. 2000. PMID: 11069723 Review.
-
Topical nonsteroidal anti-inflammatory drugs for osteoarthritis.Postgrad Med. 2010 Nov;122(6):98-106. doi: 10.3810/pgm.2010.11.2227. Postgrad Med. 2010. PMID: 21084786 Review.
Cited by
-
Long-term supplementation with an undenatured type-II collagen (UC-II®) formulation in dogs with degenerative joint disease: Exploratory study.Open Vet J. 2022 Jan-Feb;12(1):91-98. doi: 10.5455/OVJ.2022.v12.i1.11. Epub 2022 Feb 5. Open Vet J. 2022. PMID: 35342740 Free PMC article.
-
Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.Ann Rheum Dis. 2007 May;66(5):639-45. doi: 10.1136/ard.2006.059899. Epub 2007 Jan 4. Ann Rheum Dis. 2007. PMID: 17204566 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical